70 results
424B2
AQST
Aquestive Therapeutics Inc
24 Apr 24
Prospectus for primary offering
6:25am
; and
Up to 214,129 commitment shares issuable to Lincoln Park Capital Fund LLC pursuant to the Purchase Agreement, dated April 22, 2022 (the “Lincoln … ; and
Up to 214,129 commitment shares issuable to Lincoln Park Capital Fund LLC pursuant to the Lincoln Park Purchase Agreement, in connection
424B5
AQST
Aquestive Therapeutics Inc
21 Mar 24
Prospectus supplement for primary offering
4:06pm
available for future purchases under our Employee Stock Purchase Plan as of December 31, 2023; and
Up to 214,129 commitment shares issuable to Lincoln … , 2023; and
S-12
Up to 214,129 commitment shares issuable to Lincoln Park Capital Fund LLC pursuant to the Lincoln Park Purchase Agreement
424B5
AQST
Aquestive Therapeutics Inc
19 Mar 24
Prospectus supplement for primary offering
5:18pm
of common stock available for future purchases under our Employee Stock Purchase Plan as of December 31, 2023; and
Up to 214,129 commitment shares … ; and
Up to 214,129 commitment shares issuable to Lincoln Park Capital Fund LLC pursuant to the Lincoln Park Purchase Agreement, in connection
8-K
EX-4.1
q5ypop mgcc2uh6hnwow
2 Nov 23
Aquestive Therapeutics Completes $45 Million Debt Refinancing
8:45am
8-K
EX-10.1
1w6a2ryesc8
2 Nov 23
Aquestive Therapeutics Completes $45 Million Debt Refinancing
8:45am
8-K
EX-99.1
djsp y45c
2 May 23
Aquestive Therapeutics Reports First Quarter 2023 Financial Results and Provides Business Update
5:07pm
8-K
EX-1.1
qgrndrki
8 Jun 22
Aquestive Therapeutics, Inc. Announces $8.5 Million Registered Direct Offering
4:22pm
8-K
EX-99.1
upahz cl8tpu5
17 May 22
Aquestive Therapeutics Announces CEO Transition
4:10pm